Mounjaro®
Starting from £179.99/mo
Start journey Learn moreIf you're searching for who is selling Mounjaro at the cheapest price in the UK, the honest answer is: private prices vary by dose and provider, and any legitimate price includes a prescription following clinical assessment — there is no legal route around that. Since Eli Lilly raised its UK list price in September 2025, reported private prices range from roughly £149 to £375 per four-week pen depending on the dose and the service; the wide spread reflects what different providers include, and what they quietly leave out. Mounjaro is a prescription-only medicine, which means a qualified prescriber must assess your suitability before it can be dispensed — and that clinical step is not optional, regardless of where you buy.
At your door the next working day.
Free, tracked, plain packaging.
BMI isn't the whole story, but it's where clinicians start. Check yours in ten seconds — nothing is stored, nothing is shared.
Ten seconds. Private — nothing is stored or shared.
Your result updates live in the card alongside.
Your result
Your BMI is
—
which is in the healthy weight range
Start journeyBMI doesn't determine eligibility — only a clinician can assess whether treatment is right for you.
The problem
The nume way
clinician review. Free next working day delivery.
How it works
Tell us about your health, history and goals. Free, online, and confidential — no commitment, no waiting room.
Our team reviews your health the same day — never an algorithm, and approves your treatment there and then if eligible.
Order by 12pm, dispatched same day, delivered free the next working day — the nume Promise.
Private Mounjaro pricing in the UK is set per four-week pen, and it moves with the dose. The starter pen (2.5mg) tends to sit at the lower end of the market range; by the time a patient reaches 10mg or 15mg, the cost per pen is considerably higher, Eli Lilly's raised list price from September 2025 pushed the 15mg pen's list price from around £122 to around £330, and private providers price from there upwards, as widely reported in August 2025. That spread (roughly £149 to £375 depending on dose and clinic) is the realistic UK market context, hedged because prices shift and providers differ. A fuller breakdown of how Mounjaro pricing works across doses is worth reading before you commit to any service. The point is that a headline number tells you almost nothing on its own.
For people curious whether NHS access might apply to them, our Mounjaro overview covers the phased NHS rollout and strict eligibility criteria, which remain narrow for now. Private treatment through a regulated pharmacy is the route most people take.
The cheapest listing you find probably quotes the medicine alone. What it may not price in: the consultation fee (some providers charge £30–£50 separately), the prescription charge, delivery costs, and any aftercare or dose-review support if side effects appear or a titration decision needs making. A service priced at £10 less per pen but charging £40 for a consultation and £8 for delivery isn't cheaper, it's just less transparent. Payday searches and Monday morning orders often come with that optimism of getting a great deal; it's worth doing the arithmetic on the full cost before clicking through, especially if you've been searching for who sells the cheapest Mounjaro and want to understand what those prices actually include. Our guide to the cheapest Mounjaro UK options walks through what these add-ons typically cost across providers. At nume, one price covers everything: consultation, prescription, medicine, and next-working-day delivery, we publish that price clearly on our treatment page, with nothing deducted later.
We're not the cheapest, and that is a deliberate choice. Competitive clinical infrastructure costs money. Our prescribers review every consultation personally, the same day. That is not something that scales cheaply, and we don't want it to.
Mounjaro is a Black Triangle medicine, still under additional MHRA monitoring. Getting it from a source that skips or trivialises the clinical assessment is not a saving, it is a risk. The MHRA has issued repeated warnings about fake weight-loss pens sold online and via social media; in October 2025, the first UK manufacturing site producing counterfeit tirzepatide pens was raided, and enforcement across 2025 seized roughly 20 million doses with an estimated street value of around £45 million. Some counterfeit pens have been found to contain insulin rather than tirzepatide, a potentially dangerous substitution. You can verify any online pharmacy on the GPhC register; if a seller can't be found there, stop. Red flags include prices that fall well below the market range, and sellers offering these medicines without a prescription or clinical assessment. If you're comparing providers and wondering who is the cheapest for Mounjaro, that comparison is only meaningful once you've confirmed each provider is legitimate and clinically robust. Understanding what drives Mounjaro's price helps you separate legitimate services from ones that should concern you. For guidance on reporting suspect sellers, the MHRA's Yellow Card scheme accepts reports from patients directly.
The right metric for a prescription medicine is not cost per pen. It is: is the supply chain genuine, is the clinical oversight real, and is there someone available when something unexpected happens? Those are the questions that keep you safe, and they matter far more than asking who has the cheapest Mounjaro without the full clinical picture. Speak to our prescribers through a free consultation and see what clinical care alongside treatment actually looks like.
The people
Superintendent Pharmacist (GPhC No. 2217101)
Accountable for the safe running of our registered pharmacy, from every dispensing check to every dispatch.
Clinical Lead (GPhC No. 2231744)
Sets our clinical standards and checks everything we publish against current MHRA guidance.
Independent Prescriber (GPhC No. 2084501)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.
Independent Prescriber (GPhC No. 2083426)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.